Filing Details
- Accession Number:
- 0000874015-13-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-03 19:46:23
- Reporting Period:
- 2013-01-01
- Filing Date:
- 2013-01-03
- Accepted Time:
- 2013-01-03 19:46:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537529 | P Brett Monia | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Vp, Antisense Drug Discovery | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-01 | 215 | $8.87 | 5,599 | No | 5 | J | Direct | |
| Common Stock | Disposition | 2013-01-03 | 311 | $10.84 | 5,288 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reporting 215 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on January 1, 2013. These 215 shares may not be sold until July 2, 2013.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/24/2011.
Billionaire Hedge Funds
